Fibrobiologics, Common Stock Stock Price on December 4, 2024
| FBLG Stock | 2.22 0.07 3.26% |
If you're considering investing in FibroBiologics, Stock, it is important to understand the factors that can impact its price. As of today, the current price of FibroBiologics, Common stands at 2.22, as last reported on the 18th of December 2024, with the highest price reaching 2.22 and the lowest price hitting 2.15 during the day. FibroBiologics, Common secures Sharpe Ratio (or Efficiency) of -0.0613, which denotes the company had a -0.0613% return per unit of standard deviation over the last 3 months. FibroBiologics, Common Stock exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm FibroBiologics, Common's Standard Deviation of 6.39, coefficient of variation of (1,506), and Mean Deviation of 4.93 to check the risk estimate we provide.
At this time, FibroBiologics, Common's Issuance Of Capital Stock is most likely to increase significantly in the upcoming years. . At this time, FibroBiologics, Common's Price Fair Value is most likely to increase significantly in the upcoming years. FibroBiologics, Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
FibroBiologics, |
Sharpe Ratio = -0.0613
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | FBLG |
Estimated Market Risk
| 6.53 actual daily | 58 58% of assets are less volatile |
Expected Return
| -0.4 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average FibroBiologics, Common is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of FibroBiologics, Common by adding FibroBiologics, Common to a well-diversified portfolio.
Price Book 27.3525 | Book Value 0.081 | Enterprise Value 68.6 M | Shares Float 24.9 M | Shares Outstanding 34.7 M |
Related Headline
MYR Headline on 4th of December 2024
Verition Fund Management LLC Buys New Stake in MYR Group Inc... by news.google.com
Verition Fund Management LLC Buys New Stake in MYR Group Inc. MarketBeat
FibroBiologics, Common Valuation on December 4, 2024
It is possible to determine the worth of FibroBiologics, Common on a given historical date. On December 4, 2024 FibroBiologics, was worth 2.57 at the beginning of the trading date compared to the closed value of 2.46. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of FibroBiologics, Common stock. Still, in general, we apply an absolute valuation method to find FibroBiologics, Common's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of FibroBiologics, Common where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against FibroBiologics, Common's related companies.
| Open | High | Low | Close | Volume | |
| 2.71 | 2.71 | 2.53 | 2.60 | 100,307 | |
12/04/2024 | 2.57 | 2.61 | 2.33 | 2.46 | 153,467 |
| 2.46 | 2.53 | 2.23 | 2.38 | 113,247 |
| Backtest FibroBiologics, Common | | | FibroBiologics, Common History | | | FibroBiologics, Common Valuation | Previous | Next |
FibroBiologics, Common Trading Date Momentum on December 4, 2024
| On December 05 2024 FibroBiologics, Common Stock was traded for 2.38 at the closing time. The top price for the day was 2.53 and the lowest listed price was 2.23 . The trading volume for the day was 113.2 K. The trading history from December 5, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 3.25% . The overall trading delta against the current closing price is 12.20% . |
FibroBiologics, Common Fundamentals Correlations and Trends
By evaluating FibroBiologics, Common's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among FibroBiologics, Common's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. FibroBiologics, financial account trend analysis is a perfect complement when working with valuation or volatility modules.About FibroBiologics, Common Stock history
FibroBiologics, Common investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for FibroBiologics, is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in FibroBiologics, Common will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing FibroBiologics, Common stock prices may prove useful in developing a viable investing in FibroBiologics, Common
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 28.2 M | 28 M |
FibroBiologics, Common Stock Technical Analysis
FibroBiologics, Common technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
FibroBiologics, Common Period Price Range
Low | December 18, 2024
| High |
0.00 | 0.00 |
FibroBiologics, Common Stock cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
FibroBiologics, Common December 18, 2024 Market Strength
Market strength indicators help investors to evaluate how FibroBiologics, Common stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading FibroBiologics, Common shares will generate the highest return on investment. By undertsting and applying FibroBiologics, Common stock market strength indicators, traders can identify FibroBiologics, Common Stock entry and exit signals to maximize returns
FibroBiologics, Common Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for FibroBiologics, Common's price direction in advance. Along with the technical and fundamental analysis of FibroBiologics, Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of FibroBiologics, to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.66) | |||
| Total Risk Alpha | (0.94) | |||
| Treynor Ratio | (0.11) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for FibroBiologics, Stock analysis
When running FibroBiologics, Common's price analysis, check to measure FibroBiologics, Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy FibroBiologics, Common is operating at the current time. Most of FibroBiologics, Common's value examination focuses on studying past and present price action to predict the probability of FibroBiologics, Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move FibroBiologics, Common's price. Additionally, you may evaluate how the addition of FibroBiologics, Common to your portfolios can decrease your overall portfolio volatility.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |